Cancer Treatment

Partner Therapeutics Files sBLA for BIZENGRI in CCA

LEXINGTON, MASSACHUSETTS, USA, April 14, 2026 Partner Therapeutics, Inc. has announced the submission of a supplemental Biologics License Application...

By cGxPwire Editor
April 15, 2026

Bio-Pharma

Cardinal Health Expands Ac-225 Supply for Cancer Therapies

Dublin, Ohio, USA – April 1, 2026 In a significant advancement for the rapidly evolving field of targeted cancer...

By cGxPwire Editor
April 2, 2026

Pharma

Sanofi Sarclisa SC Wins CHMP Nod for Myeloma Care

Paris, France | March 27, 2026 CHMP Recommends Innovative Subcutaneous Formulation Sanofi has achieved a major regulatory milestone as...

By cGxPwire Editor
March 30, 2026

MedTech

IceCure Reports Strong 5-Year Results in Kidney Cancer

CAESAREA, Israel, March 25, 2026 IceCure Medical has reported positive five-year top-line results from its ICESECRET clinical trial, demonstrating...

By cGxPwire Editor
March 26, 2026

Bio-Pharma

Hemostemix Advances ACP-01 With FDA Pre-IND Milestone

CALGARY, Alberta, Dec. 10, 2025 — Hemostemix Inc., a leader in autologous stem cell therapeutics, announced two pivotal corporate...

By cGxPwire Editor
December 11, 2025

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

Pharma

Scemblix® Gets Priority Access Under Ontario’s FAST Program

MONTREAL, QC, Dec. 10, 2025 — Scemblix® (asciminib) has become one of the first therapies prioritized for public reimbursement...

By cGxPwire Editor
December 11, 2025

Bio-Pharma

Nanobiotix to Present at Major U.S. Healthcare Events

Nanobiotix S.A. (Euronext: NANO, NASDAQ: NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches for cancer and other serious...